Sign in

CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company

Serina Therapeutics, Inc.

Sign in to watch
Ticker
SER
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
AL
Entity type
operating
EIN
821436829
Phone
(256) 327-9630
Business address
601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
Former names
AgeX Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-11-19 SEGALL JUDITH Director, Admin & Secretary Grant or award · Option to Purchase Coomon Stock +15,000 15,000
2019-08-13 Juvenescence Ltd 10% owner Purchase +19,000 16,419,000
2019-08-13 Juvenescence Ltd 10% owner Purchase · Warrant to Purchase Common Stock +150,000 150,000
2019-03-15 MAULDIN JOHN F Director Sale · Warrant to Purchase Common Stock −50,000 $1.65 $83K 0
2019-03-11 WEST MICHAEL D Chief Executive Officer Grant or award · Option to Purchase Common Stock +100,000 100,000
2019-03-11 WEST MICHAEL D Chief Executive Officer Grant or award · Restricted Stock Units +50,000 50,000
2019-03-11 STERNBERG HAL Vice President-Research Grant or award · Option to Purchase Common Stock +15,000 15,000
2019-03-11 Mulroy Michael H. Director Grant or award · Option to Purchase Common Stock +65,000 65,000
2019-03-11 MAULDIN JOHN F Director Grant or award · Option to Pruchase Common Stock +65,000 65,000
2019-03-11 MALIK NAFEES NASEER Chief Operating Officer Grant or award · Option to Purchase Common Stock +70,000 70,000
2019-03-11 Bailey Gregory Director Grant or award · Option to Purchase Common Stock +100,000 100,000
2019-03-11 Jenkins Annalisa Director Grant or award · Option to Purchase Common Stock +100,000 100,000
2018-12-10 WEST MICHAEL D Chief Executive Officer Purchase +4,000 $3.86 $15K 15,460

Page 15 of 15 · 293 trades